Details of the Drug

General Information of Drug (ID: DMAJ85O)

Drug Name
VDA-1102
Indication
Disease Entry ICD 11 Status REF
Actinic keratosis EK90.0 Phase 2 [1]
Cross-matching ID
PubChem CID
76677260
TTD ID
D06QBX

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Hexokinase-2 (HK2) TTK02H8 HXK2_HUMAN Modulator [1]
Tissue kallikrein (KLK2) TTJLNAW KLK2_HUMAN Modulator [2]
Voltage-dependent anion channel (VDAC) TTPZI04 NOUNIPROTAC Modulator [2]
Voltage-dependent anion-selective channel 1 (VDAC1) TTAMKGB VDAC1_HUMAN Modulator [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Actinic keratosis
ICD Disease Classification EK90.0
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Tissue kallikrein (KLK2) DTT KLK2 2.30E-01 -0.02 -0.2
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of Vidac Pharma.